Clinical Resistance and Decreased Susceptibility inStreptococcus suisIsolates from Clinically Healthy Fattening Pigs
- 1 April 2013
- journal article
- research article
- Published by Mary Ann Liebert Inc in Microbial Drug Resistance
- Vol. 19 (2), 146-151
- https://doi.org/10.1089/mdr.2012.0131
Abstract
Streptococcus suis (S. suis) has often been reported as an important swine pathogen and is considered as a new emerging zoonotic agent. Consequently, it is important to be informed on its susceptibility to antimicrobial agents. In the current study, the Minimum Inhibitory Concentration (MIC) population distribution of nine antimicrobial agents has been determined for nasal S. suis strains, isolated from healthy pigs at the end of the fattening period from 50 closed or semiclosed pig herds. The aim of the study was to report resistance based on both clinical breakpoints (clinical resistance percentage) and epidemiological cutoff values (non-wild-type percentage). Non-wild-type percentages were high for tetracycline (98%), lincomycin (92%), tilmicosin (72%), erythromycin (70%), tylosin (66%), and low for florfenicol (0%) and enrofloxacin (0.3%). Clinical resistance percentages were high for tetracycline (95%), erythromycin (66%), tylosin (66%), and low for florfenicol (0.3%) and enrofloxacin (0.3%). For tiamulin, for which no clinical breakpoint is available, 57% of the isolates did not belong to the wild-type population. Clinical resistance and non-wild-type percentages differed substantially for penicillin. Only 1% of the tested S. suis strains was considered as clinically resistant, whereas 47% of the strains showed acquired resistance when epidemiological cutoff values were used. In conclusion, MIC values for penicillin are gradually increasing, compared to previous reports, although pigs infected with strains showing higher MICs may still respond to treatment with penicillin. The high rate of acquired resistance against tiamulin has not been reported before. Results from this study clearly demonstrate that the use of different interpretive criteria contributes to the extent of differences in reported antimicrobial resistance results. The early detection of small changes in the MIC population distribution of isolates, while clinical failure may not yet be observed, provides the opportunity to implement appropriate risk management steps.Keywords
This publication has 38 references indexed in Scilit:
- Fluoroquinolone resistance of Escherichia coli and Salmonella from healthy livestock and poultry in the EUJournal of Applied Microbiology, 2011
- Harmonisation of resistance monitoring programmes in veterinary medicine: an urgent need in the EU?International Journal of Antimicrobial Agents, 2011
- In vitro antimicrobial susceptibility of Streptococcus suis strains isolated from clinically healthy sows in ChinaVeterinary Microbiology, 2008
- Streptococcus suis Meningitis in Adults in VietnamClinical Infectious Diseases, 2008
- Streptococcus suisinfection in Hong Kong: an emerging infectious disease?Epidemiology and Infection, 2008
- Potential confusion regarding the term 'resistance' in epidemiological surveys.Journal of Antimicrobial Chemotherapy, 2007
- Setting and Revising Antibacterial Susceptibility BreakpointsClinical Microbiology Reviews, 2007
- Streptococcus suisSequence Type 7 Outbreak, Sichuan, ChinaEmerging Infectious Diseases, 2006
- Penicillin‐Binding Protein‐Mediated Resistance in Pneumococci and StaphylococciThe Journal of Infectious Diseases, 1999
- Evaluation of Antibiotics for the Elimination of the Tonsillar Carrier State of Streptococcus Suis in PigsJournal of Veterinary Diagnostic Investigation, 1996